Try our mobile app
British American Tobacco p.l.c.
Incorporated in England and Wales
(Registration number: 03407696)
Short name: BATS
Share code: BTI
ISIN number: GB0002875804
("British American Tobacco p.l.c." or "the Company")
9 February 2023 – PRESS RELEASE / PRELIMINARY RESULTS
BRITISH AMERICAN TOBACCO p.l.c.
YEAR ENDED 31 DECEMBER 2022
New Category Acceleration Drives Profitability Forward To 2024
Jack Bowles, Chief Executive:
"We continue to accelerate our A Better TomorrowTM transformation at speed.
“Driven by our strong New Category momentum, (with revenue approaching £3bn), we are confident in our £5bn revenue target by 2025,
and now expect New Category profitability in 2024, one year ahead of plan.
"Our New Category business delivered strong volume, revenue and market share growth and has become a significant contributor to the
Group's financial delivery. In 2022, we invested more than £2bn in New Categories to drive long-term sustainable growth, while making
excellent progress in reducing operating losses by 62%.
"While reported results were impacted by a number of one-off charges, we achieved a 150 bps improvement in adjusted operating margin at
current rates and another year of 100% operating cash conversion demonstrating our ability to successfully navigate an increasingly
challenging macro-economic environment. This enabled us to return £6.9bn to shareholders in 2022. I am proud of our people and their
focus on delivery of our three strategic priorities, demonstrating once again the strength and resilience of our business.
"Looking forward, while we expect the macro-economic environment to remain challenging, we will continue to deliver and further
accelerate our transformation. We will leverage our well-established multi-category brand portfolio, our new regional structure to enable
even greater collaboration and accelerated decision-making and our new market archetype model to guide our strategic choices and resource
allocation to further enhance returns.
"I am confident in BAT's ability to deliver long-term sustainable value for shareholders."
PERFORMANCE HIGHLIGHTS REPORTED ADJUSTED
Current Vs 2021 Current Vs 2021
rates (current) Rates (current) (constant)
Cigarette and THP volume share -10 bps
Cigarette and THP value share flat
Non-Combustibles consumers1 22.5m +4.2m
Revenue (£m) £27,655m +7.7% £27,655m +7.7% +2.3%
Revenue from New Categories (£m) £2,894m +40.9% £2,894m +40.9% +37.0%
Profit from operations (£m) £10,523m +2.8% £12,408m +11.3% +4.3%
Category contribution - New Categories (£m)^ -£366m -61.6% -60.7%
Operating margin (%) 38.1% -170 bps +44.9% +150 bps +90 bps
Diluted EPS (pence) 291.9p -1.3% 371.4p +12.9% +5.8%
Net cash generated from operating activities (£m) £10,394m +7.0%
Adjusted cash generated from operations (£m) £7,889m +7.4% +3.9%
Cash conversion (%) 98.8% +390 bps +100.0% -360 bps
Borrowings2 (£m) £43,139m +8.8%
Adjusted Net Debt (£m) £38,131m +7.3% +0.5%
Dividend per share (pence) 230.9p +6.0%
The use of non-GAAP measures, including adjusting items and constant currencies, are further discussed from page Error! Bookmark not defined., with reconciliation from the most comparable IFRS measure provided.
Note – 1. Internal estimate. 2. Includes lease liabilities. ^This is an improvement in New Categories contribution as losses reduced by 61.6% (or 60.7% at constant rates of exchange).
Faster Transformation Strong FY Results
• New Category profitability expected in 2024, one year ahead of
• Revenue up 2.3%** driven by New Category growth and
target
pricing
• Non-Combustible product* consumers up 4.2m to 22.5m
• Combustible revenue underpinned by price/mix of +4.6%
• Non-Combustibles now 14.8% of revenue up 2.4 ppts from 2021
• Global Cigarette value share flat, US value share up 10 bps
• New Categories revenue up 37.0% to £2,813m** with growth in:
• Delivered £1.9bn annualised Quantum savings, well ahead of
• Vapour (+43.8%**), THP (+26.7%**), Modern Oral
original £1bn target, with £629m in 2022
(+45.6%**)
• Adjusted profit from operations up 4.3%** absorbing a
• New Category contribution losses reduced by £578m**, an
negative transactional FX impact of 1.5%
improvement of 60.7%**
• Adjusted operating margin up 90 bps**
• Double Materiality Assessment completed
• Adjusted diluted EPS up 5.8%**
• Scope 1 & 2 Greenhouse Gas emissions down 15% vs. 2021
• Operating cash flow conversion of 100%
• Achieved target of 30% renewable energy use 3 years early
• Adjusted net debt/Adjusted EBITDA 2.89x
• CDP "A" for Climate Change; DJSI World Sustainability Index
• 6.0% dividend growth
* Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive. ** at constant rates of exchange.
2023 OUTLOOK:
• Global tobacco industry volume expected to be down c.2%.
• 3-5% organic constant currency revenue growth, reported growth impacted by timing of the transfer of the Russian and Belarusian
businesses expected to close in 2023.
• Strong New Category revenue growth with further improvement in category contribution alongside incremental investment.
• Mid-single figure constant currency adjusted EPS growth, including a c.2% transactional FX headwind, with growth H2 weighted.
• Translational foreign exchange is expected to be broadly neutral on full year adjusted EPS growth.
• Operating cash flow conversion in excess of 90%.
Jack Bowles, Chief Executive Statement
Transforming at speed
"In 2022, the business demonstrated once again that we are transforming BAT while delivering strong results.
"At the core of our strategy is our corporate purpose to build A Better TomorrowTM. This means offering a greater choice of enjoyable and
less risky products*† for our consumers.
"Our results show that our strategy is working. We have strong, global New Category brands, targeted geographic expansion plans and an
unwavering commitment to innovation that ensures we are delivering for the consumer. We now have 22.5 million consumers of non-
combustible products and revenue from these products account for c.15% of Group revenue.
"Our people have always been one of our greatest strengths and this year that has never been more evident. Their focus and resolve in the
face of global economic upheaval has ensured excellent progress against our three strategic priorities to deliver:
• a step change in New Categories performance;
• value from combustibles; and
• business simplification.
"Following a comprehensive strategic review, we have taken the decision to further simplify the Group, reducing the number of regions and
business units1. At the same time, our new operating model, centred around market archetypes, will enable us to prioritise our investments
smartly and focus our activities and resource allocation to maximise returns. In addition, we expect to sell at least 20bn fewer cigarettes after
completion of our phased exits of around 30 markets, further advancing our A Better TomorrowTM purpose.
"I am also pleased to confirm that we are in advanced discussions with a joint management-distributor consortium with a view to completing
the transfer of our Russian and Belarusian businesses in 2023.
"In the Wellbeing and Stimulation space, we have made good progress in 2022, through our venturing unit, Btomorrow Ventures. In
addition, in the cannabis space, we complemented our investment in Organigram with a non-controlling minority stake in Sanity Group and
an investment in Charlotte’s Web. Together, these investments represent further steps in our exploration beyond tobacco and nicotine.
"With ESG being central to our strategy, further embedding our commitment to sustainability, we appointed our first Chief Sustainability
Officer. In 2022, we were one of the first companies globally to implement a comprehensive Double Materiality Assessment, well ahead of
regulatory requirements, providing insights to guide the business through 2023 and beyond.
"With the external environment becoming ever more complex, I am confident that BAT's proven resilience and performance will ensure we
will capitalise on emerging opportunities as we continue to deliver value for stakeholders now and in the future."
Tadeu Marroco, Finance & Transformation Director's Statement
Continued delivery in a challenging macro-environment:
“Our 2022 full-year performance demonstrates that we are delivering and transforming at speed, driven by our multi-category portfolio of
global brands. Having invested significantly, New Categories are now a meaningful contributor to Group results, delivering a strong £578
million improvement in profitability as New Category losses reduced by 61% at constant rates.
"Our consumer-centric, multi-category approach is driving continued momentum in our New Categories, underpinned by our exciting
pipeline of innovations and further geographic expansion, with our products now available in 60 countries globally, and around 90 category-
market combinations. Our increasing scale is driving operating leverage, while further automation is reducing the cost of goods sold. In
addition, our growing brand equity has enabled us to increase pricing on both devices and consumables in key markets. This strong
momentum has enabled us to bring forward our New Category profitability target by one year to 2024.
"In combustibles, our targeted portfolio of brands across price tiers delivered a robust performance across APME, AmSSA and Europe
driven by resilient volumes and strong pricing, partly offset by mainly geographic mix and the disposal of our Iranian business in August
2021. In the U.S., industry volumes were impacted by normalisation of consumption patterns post COVID-19 and growing macro-economic
pressures in the second half of 2022. In addition, our volumes reflect the partial unwind of prior year inventory movements. Our
combustibles value share in the U.S. grew by 10 bps, together with an excellent Vuse performance and a translational FX tailwind driving
profit from operations up 11.5%. Adjusted profit from operations was up 3.5%, excluding higher adjusting items and translational FX.
"Group reported profit from operations was up 2.8%, with reported operating margin down 170 bps and reported diluted EPS down 1.3%.
Our reported results were affected by a number of adjusting items including charges (£612 million) in respect of Russia and Belarus
(described on page Error! Bookmark not defined.), a charge (£450 million) related to the investigation in respect of alleged historical
breaches of sanctions (described on page Error! Bookmark not defined.) and other restructuring charges (£771 million) largely related to
Project Quantum. These were more than offset by a translational foreign exchange tailwind and a net credit in Brazil (£460 million) in
relation of historical VAT on social contributions.
"We are successfully navigating the challenging external environment, delivering 150 bps adjusted operating margin growth, while
absorbing a 1.5% impact from transactional foreign exchange. This was driven by our increased agility and resilience, in addition to £1.9
billion annualised savings from Project Quantum, delivering well ahead of our original target of £1bn annualised savings by the end of 2022.
Adjusted profit from operations increased 11.3% (or 4.3% at constant currency) with adjusted diluted EPS up 12.9%, or 5.8% at constant
currency, delivering at the top end of our mid-single digit guidance.
"Our business is highly cash generative; we achieved another year of excellent operating cash conversion, delivering 100%, well ahead of
our 90% guidance and we expect as a Group to generate c.£40 billion of free cash flow before dividends over the next five years.
"The Board reviews our capital allocation priorities taking into account the macro-economic environment and potential regulatory and
litigation outcomes. At this time, the Board has decided to take a pragmatic approach. Given our incremental investment plans in 2023 to
further accelerate our transformation, and in light of the uncertain macro environment, higher interest rates, outstanding litigation and
regulatory matters, the Board has decided to prioritise strengthening the balance sheet. This will provide greater business resilience while
continuing to support future financial agility, as we aim to reduce leverage more quickly towards the middle of our target 2-3x corridor. In
line with our progressive dividend policy, the dividend will increase by 6.0% to 230.9p.
"We strongly believe that share buy-backs have an important role to play within our capital allocation framework, and we will continue to
keep it under review as we progress through the year.
"Liquidity remains strong with average debt maturity close to 10 years, and a fixed debt-profile of over 95%. Our medium-term rating target
remains Baa1/BBB+, with a current rating of Baa2 (stable outlook)/BBB+ (negative outlook)**.
"We are in our "Faster Transformation" phase, driven by our well-established consumer-centric, multi-category strategy, strong portfolio of
global brands and our resilient, highly cash generative business. This will enable us to further invest in and accelerate the transformation of
our business, as we continue to build A Better TomorrowTM.”
* Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
** A credit rating is not a recommendation to buy, sell or hold securities. A credit rating may be subject to withdrawal or revision at any time. Each rating should be evaluated separately of any other rating.
† Our vapour product Vuse (including Alto, Solo, Ciro and Vibe), and certain products, including Velo, Grizzly, Kodiak, and Camel Snus, which are sold in the U.S., are subject to FDA regulation and no reduced-risk claims
will be made as to these products without agency clearance. 1. Subject to applicable information and consultation requirements in some jurisdictions.
Other Information
DIVIDENDS
The Board has declared an interim dividend of 230.9p per ordinary share of 25p, for the year ended 31 December 2022, payable in four
equal quarterly instalments of 57.72p per ordinary share in May 2023, August 2023, November 2023 and February 2024. This represents an
increase of 6.0% on 2021 (2021: 217.8p per share), and a payout ratio, on 2022 adjusted diluted earnings per share, of 62.2%.
The quarterly dividends will be paid to shareholders registered on either the UK main register or the South Africa branch register and to
holders of American Depositary Shares (ADSs), each on the applicable record dates set out under the heading ‘Key Dates’ below.
General dividend information
Under IFRS, the dividend is recognised in the year that it is approved by shareholders or, if declared as an interim dividend by directors, in
the period that it is paid.
The cash flow, prepared in accordance with IFRS, reflects the total cash paid in the period, amounting to £4,915 million (2021: £4,904
million).
2022 2021
Pence per USD per Pence per
Dividends declared: USD per ADS
share ADS share
Quarterly Payment 1 (paid May 2022) 54.45 0.6804340 53.90 0.7576180
Quarterly Payment 2 (paid August 2022) 54.45 0.6555230 53.90 0.7345300
Quarterly Payment 3 (paid November 2022) 54.45 0.6355400 53.90 0.7217210
Quarterly Payment 4 (paid February 2023) 54.45 0.6691900 53.90 0.7298860
217.80 2.6406870 215.60 2.9437550
Holders of ADSs
For holders of ADSs listed on the New York Stock Exchange (NYSE), the record dates and payment dates are set out below. The equivalent
quarterly dividends receivable by holders of ADSs in U.S. dollars will be calculated based on the exchange rate on the applicable payment
date. A fee of US$0.005 per ADS will be charged by Citibank, N.A. in its capacity as depositary bank for the BAT American Depositary
Receipt (ADR) programme in respect of each quarterly dividend payment.
South Africa Branch Register
In accordance with the JSE Limited (JSE) Listing Requirements, the finalisation information relating to shareholders registered on the South
Africa branch register (comprising the amount of the dividend in South African rand, the exchange rate and the associated conversion date)
will be published on the dates stated below, together with South Africa dividends tax information.
The quarterly dividends are regarded as ‘foreign dividends’ for the purposes of the South Africa Dividends Tax. For the purposes of South
Africa Dividends Tax reporting, the source of income for the payment of the quarterly dividends is the United Kingdom.
Key dates
In compliance with the requirements of the London Stock Exchange (LSE), the NYSE and Strate, the electronic settlement and custody
system used by the JSE, the following salient dates for the quarterly dividends payments are applicable. All dates are 2023, unless otherwise
stated.
Event Payment No. 1 Payment No. 2 Payment No. 3 Payment No. 4
Preliminary announcement (includes
declaration data required for JSE 09 February
purposes)
Publication of finalisation information
13 March 04 July 18 September 12 December
(JSE)
No removal requests permitted (in
either direction) between the UK main 13 March– 18 September– 12 December–
04 July - 17 July
register and the South Africa branch 27 March 02 October 27 December
register
Last Day to Trade (LDT) cum-dividend
20 March 11 July 26 September 19 December
(JSE)
Shares commence trading ex-dividend
22 March 12 July 27 September 20 December
(JSE)
No transfers permitted between the UK
22 March– 12 July– 27 September– 20 December–
main register and the South Africa
27 March 17 July 02 October 27 December
branch register
No shares may be dematerialised or
22 March– 12 July– 27 September– 20 December–
rematerialised on the South Africa
27 March 17 July 02 October 27 December
branch register
Shares commence trading ex-dividend
23 March 13 July 28 September 21 December
(LSE)
Shares commence trading ex-dividend
23 March 13 July 28 September 21 December
(NYSE)
Record date
24 March 14 July 29 September 22 December
(JSE, LSE and NYSE)
Last date for receipt of Dividend
Reinvestment Plan (DRIP) elections 11 April 28 July 13 October 11 January 2024
(LSE)
Payment date (LSE and JSE) 03 May 18 August 03 November 01 February 2024
ADS payment date (NYSE) 08 May 23 August 08 November 06 February 2024
Note:
(1) The dates set out above may be subject to any changes to public holidays arising and changes or revisions to the LSE, JSE and NYSE
timetables. Any confirmed changes to the dates will be announced.
SHORT-FORM ANNOUNCEMENT
This short-form announcement is the responsibility of the Directors of the Company. It is only
a summary of the information contained in the full Preliminary Announcement – Year Ended 31
December 2022 (the “Results Announcement”) and does not contain full or complete details. Any
investment decisions should be based on consideration of the full Results Announcement
available via the JSE at https://senspdf.jse.co.za/documents/2023/JSE/ISSE/BTI/BATFY22.pdf and
on the Company’s website at www.bat.com. Copies of the full Results Announcement may also be
obtained during normal business hours from the Company’s registered office and the Company’s
representative office in South Africa. Contact details are set out below.
SHAREHOLDER INFORMATION
FINANCIAL CALENDAR 2023*
Wednesday 19 April Annual General Meeting at 11.30 am
Details of the venue and business to be proposed at
the meeting will be set out in the Notice of AGM, which
will be made available to all shareholders and published
on www.bat.com.
The format for the 2023 AGM will be contingent on applicable UK
Government health and safety restrictions in place at that time.
Thursday 27 July Half-Year Report
* Indicated dates are subject to change
CORPORATE INFORMATION
Premium listing
London Stock Exchange (Share Code: BATS; ISIN: GB0002875804)
Computershare Investor Services PLC
The Pavilions, Bridgwater Road, Bristol BS99 6ZZ, UK
tel: 0800 408 0094; +44 370 889 3159
Share dealing tel: 0370 703 0084 (UK only)
Your account: www.computershare.com/uk/investor/bri
Share dealing: www.computershare.com/dealing/uk
Web-based enquiries: www.investorcentre.co.uk/contactus
Secondary listing
JSE (Share Code: BTI)
Shares are traded in electronic form only and transactions settled electronically through Strate.
Computershare Investor Services Proprietary Limited
Private Bag X9000, Saxonwold 2132, South Africa
tel: 0861 100 634; +27 11 870 8216
email enquiries: web.queries@computershare.co.za
Sponsor for the purpose of the JSE
UBS South Africa (Pty) Ltd
American Depositary Receipts (ADRs)
NYSE (Symbol: BTI; CUSIP Number: 110448107)
BAT’s shares are listed on the NYSE in the form of American Depositary Shares (ADSs) and these are evidenced by American Depositary
Receipts (ADRs), each one of which represents one ordinary share of British American Tobacco p.l.c. Citibank, N.A. is the depositary bank
for the sponsored ADR programme.
Citibank Shareholder Services
PO Box 43077, Providence, Rhode Island 02940-3077, USA
tel: +1 888 985 2055 (toll-free) or +1 781 575 4555
email enquiries: citibank@shareholders-online.com
website: www.citi.com/dr
Publications
British American Tobacco Publications
Unit 80, London Industrial Park, Roding Road, London E6 6LS, UK
tel: +44 20 7511 7797
e-mail enquiries: bat@team365.co.uk or the Company’s Representative office in South Africa using the contact details shown below.
British American Tobacco p.l.c.
Registered office
Globe House, 4 Temple Place, London, WC2R 2PG, UK
tel: +44 20 7845 1000;
British American Tobacco p.l.c. is a public limited company which is listed on the London Stock Exchange, New York Stock Exchange and
the JSE Limited in South Africa. British American Tobacco p.l.c. is incorporated in England and Wales (No. 3407696) and domiciled in the
UK.
British American Tobacco p.l.c.
Representative office in South Africa
Waterway House South
No 3 Dock Road, V&A Waterfront, Cape Town 8000
South Africa
PO Box 631, Cape Town 8000, South Africa
tel: +27 21 003 6712
ENQUIRIES
INVESTOR RELATIONS: MEDIA:
Victoria Buxton +44 (0)20 7845 2012 BAT Media Centre +44 (0)20 7845 2888
Yetunde Ibe +44 (0)20 7845 1095
John Harney +44 (0)20 7845 1263
Live webcast of FY22 Results Presentation at 09.30am GMT on 9 February 2023
Jack Bowles, Chief Executive, and Tadeu Marroco, Finance and Transformation Director, will host a presentation of the results followed by
a Q&A session. We appreciate it is a busy reporting day, so we will be hosting our full-year results presentation as a virtual event. The
presentation will be webcast live from 9.30am GMT, in listen-only mode on http://www.bat.com.
If you wish to ask a question, please join the call using the telephone numbers below, quoting ‘BAT’ when prompted by the operator.
United Kingdom (toll): +44 (0) 33 0551 0200 SA (toll free): 0 800 980 512
United Kingdom (toll free): 0808 109 0700 U.S. (toll free): 866 580 3963
A video playback of the presentation will be available online and via our BAT IR app, alongside the slides and script for the results
presentation.
A full transcript will be available 24 hours after the event .
FORWARD-LOOKING STATEMENTS AND OTHER MATTERS
This announcement contains certain forward-looking statements, including "forward-looking" statements made within the meaning of the
U.S. Private Securities Litigation Reform Act of 1995.
In particular, these forward-looking statements include, among other statements, statements regarding the Group's future financial
performance, planned product launches and future regulatory developments and business objectives (including with respect to sustainability
and other environmental, social and governance matters), as well as: (i) certain statements in the New Categories Acceleration Drives
Profitability Forward To 2024 section and in the Chief Executive Statement (pages 1 to Error! Bookmark not defined.); (ii) certain
statements in the Finance and Transformation Director’s Statement (page 3); (iii) certain statements in the Group Operating Review (page
Error! Bookmark not defined.); (iv) certain statements in the Category Performance Review (pages Error! Bookmark not defined. to
Error! Bookmark not defined.); (v) certain statements in the Regional Review section (pages Error! Bookmark not defined. to Error!
Bookmark not defined.); (vi) certain statements in the Other Financial Information section (pages Error! Bookmark not defined. to
Error! Bookmark not defined.); (vii) certain statements in the Other Information section (pages Error! Bookmark not defined. to Error!
Bookmark not defined.); (viii) certain statements in the Notes to the Financial Statements section (pages Error! Bookmark not defined.
to Error! Bookmark not defined.), including the Liquidity and Contingent Liabilities and Financial Commitments sections; and (ix) certain
statements in the Other Information section (pages Error! Bookmark not defined. to 5), including the Non-GAAP Measures sections and
under the heading “Dividends”.
These statements are often, but not always, made through the use of words or phrases such as "believe," "anticipate," "could," "may,"
"would," "should," "intend," "plan," "potential," "predict," "will," "expect," "estimate," "project," "positioned," "strategy," "outlook,"
"target" and similar expressions. These include statements regarding our intentions, beliefs or current expectations concerning, amongst
other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the economic and business
circumstances occurring from time to time in the countries and markets in which the British American Tobacco Group (the “Group”)
operates, including the projected future financial and operating impacts of the COVID-19 pandemic.
All such forward-looking statements involve estimates and assumptions that are subject to risks, uncertainties and other factors. It is
believed that the expectations reflected in this announcement are reasonable, but they may be affected by a wide range of variables that
could cause actual results and performance to differ materially from those currently anticipated. Among the key factors that could cause
actual results to differ materially from those projected in the forward-looking statements are uncertainties related to the following: the
impact of competition from illicit trade; the impact of adverse domestic or international legislation and regulation; the inability to develop,
commercialise and deliver the Group’s New Categories strategy; adverse litigation and dispute outcomes and the effect of such outcomes on
the Group’s financial condition; the impact of significant increases or structural changes in tobacco, nicotine and New Categories related
taxes; translational and transactional foreign exchange rate exposure; changes or differences in domestic or international economic or
political conditions; the ability to maintain credit ratings and to fund the business under the current capital structure; the impact of serious
injury, illness or death in the workplace; adverse decisions by domestic or international regulatory bodies; changes in the market position,
businesses, financial condition, results of operations or prospects of the Group; and direct and indirect adverse impacts associated with
Climate Change and the move towards a Circular Economy.
A review of the reasons why actual results and developments may differ materially from the expectations disclosed or implied within
forward-looking statements can be found by referring to the information contained under the headings “Cautionary statement”, "Group
Principal Risks" and "Group Risk Factors" in the 2021 Annual Report and Accounts and Form 20-F of British American Tobacco p.l.c.
(BAT). Additional information concerning these and other factors can be found in BAT's filings with the U.S. Securities and Exchange
Commission (SEC), including the Annual Report on Form 20-F and Current Reports on Form 6-K, which may be obtained free of charge at
the SEC's website, http://www.sec.gov and BAT’s Annual Reports, which may be obtained free of charge from the British American
Tobacco website www.bat.com.
No statement in this announcement is intended to be a profit forecast and no statement in this communication should be interpreted to mean
that earnings per share of BAT for the current or future financial years would necessarily match or exceed the historical published earnings
per share of BAT. Past performance is no guide to future performance and persons needing advice should consult an independent financial
adviser. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and
BAT undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or
otherwise. Readers are cautioned not to place undue reliance on such forward-looking statements.
All financial statements and financial information provided by or with respect to the U.S. or Reynolds American are initially prepared on the
basis of U.S. GAAP and constitute the primary financial statements or financial records of the U.S. / Reynolds American. This financial
information is then converted to International Financial Reporting Standards as issued by the IASB and as adopted for use in the UK (IFRS)
for the purpose of consolidation within the results of the Group. To the extent any such financial information provided in this announcement
relates to the U.S. or Reynolds American it is provided as an explanation of, or supplement to, Reynolds American’s primary U.S. GAAP
based financial statements and information.
Our Vapour product Vuse (including Alto, Solo, Ciro and Vibe), and certain products including Velo, Grizzly, Kodiak, Camel Snus and
Granit, which are sold in the U.S., are subject to FDA regulation and no reduced-risk claims will be made as to these products without
Agency clearance.
9 February 2023
Sponsor: Merrill Lynch South Africa (Pty) Ltd t/a BofA Securities
